Neem's Hill AB (FRA:8V6)

Market Cap	7.25M +11.9%
Revenue (ttm)	1.09M +22.4%
Net Income	-721.23K
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.2260
Previous Close	0.2260
Day's Range	0.2260 - 0.2260
52-Week Range	0.1270 - 0.6800
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Neem's Hill AB

Neem's Hill AB, a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally. It offers IQwave, an electroporation that generates tumor-specific electrical stimulation for the treatment of solid superficial tumors of various sizes and locations. Neem's Hill AB was formerly known as Scandinavian ChemoTech AB (publ) and changed its name to Neem's Hill AB in July 2026. The company was incorporated in 2013 and is headquartered in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2013
• Employees: 1
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8V6

Financial Performance

In 2025, Neem's Hill AB's revenue was 12.29 million, an increase of 87.10% compared to the previous year's 6.57 million. Losses were -8.06 million, -41.27% less than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error